Voyager Therapeutics Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 10.1 | 7.3 | 4.5 | 8.6 | – | – | – | – | – | – | 3.3 | 5.2 | 6.5 | 2.9 | – | 50.5 | 13.2 | – | – | – | – | – | – | – | |
| 18.1 | 22.8 | 31.4 | 28.1 | 87.6 | 48.0 | 62.1 | 56.6 | 50.9 | 39.9 | 53.7 | 18.6 | 8.6 | 4.9 | 2.9 | 4.7 | 2.0 | 1.6 | 1.1 | 1.2 | 6.2 | 2.7 | 9.2 | 7.3 | 3.3 | 5.7 | 1.7 | 2.6 | 2.2 | 1.5 | 4.5 | 3.2 | 2.1 | 4.1 | 3.0 | 4.3 | 8.8 | 5.7 | 6.4 | 6.1 | |
| 2.0 | 2.4 | 2.8 | 2.2 | 6.3 | 3.6 | 6.1 | 7.6 | 9.3 | 6.5 | 6.3 | 8.7 | 5.8 | 5.2 | 4.3 | 6.1 | 2.4 | 1.7 | 1.3 | 1.4 | 1.1 | 1.1 | 3.8 | 3.8 | 2.9 | 4.0 | 1.5 | 2.5 | 1.9 | 1.6 | 1.6 | 1.4 | 1.0 | 1.1 | 0.7 | 0.7 | 1.3 | 1.2 | 1.3 | 1.4 | |
| 14.3 | 20.2 | 27.3 | 20.1 | 79.8 | 44.9 | 47.5 | 51.2 | 47.4 | – | 44.9 | 17.2 | 7.5 | 4.1 | 1.5 | 3.3 | 1.3 | 1.0 | 0.4 | 0.3 | -0.5 | -0.3 | 5.2 | 4.9 | 2.0 | 3.4 | 0.3 | 1.3 | 1.8 | 1.3 | 3.3 | 2.7 | 1.4 | 3.3 | 2.0 | 3.4 | 7.6 | 4.2 | 5.4 | 5.3 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 6.3 | 5.4 | 2.1 | 4.3 | – | – | – | – | – | – | 0.6 | 2.6 | 4.9 | 2.3 | 152.1 | 30.9 | 8.0 | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | 11.2 | 21.9 | 14.8 | 12.6 | – | – | – | – | – | – | – | – | 313.3 | 54.6 | 25.9 | – | 4.4 | 5.5 | 4.0 | 5.1 | 64.5 | – | – | – | – | – | – | – | – | – | |
| -13.2% | -14.7% | -16.1% | -26.4% | -12.5% | -13.4% | -0.2% | -1.3% | -1.7% | -6.6% | 8.9% | 4.6% | 6.8% | 7.9% | -33.4% | -22.0% | -27.3% | -40.5% | -56.8% | -64.9% | -93.2% | -54.0% | 0.3% | 1.8% | 3.9% | -6.4% | 22.7% | 18.3% | 25.1% | 19.7% | 1.5% | -4.9% | -8.4% | -5.7% | -57.5% | -63.7% | -43.0% | -59.0% | -56.0% | -57.3% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| -130.7% | -197.1% | -338.4% | -530.5% | -902.4% | -514.4% | -555.9% | -483.5% | -412.9% | -751.9% | -530.7% | -51.1% | -31.4% | -11.6% | -5.7% | -28.2% | 37.5% | 36.4% | 38.1% | 32.8% | -415.0% | -97.2% | -108.4% | -90.2% | 14.6% | -48.5% | 65.9% | 61.8% | 48.9% | 72.9% | 57.7% | 58.0% | 60.5% | -20.2% | -89.0% | -195.7% | -320.0% | -227.6% | -178.6% | -104.2% | |
| -207.8% | -290.4% | -473.1% | -726.4% | -1,192.6% | -709.1% | -784.8% | -749.2% | -671.5% | -1,195.6% | -836.2% | -116.3% | -82.8% | -49.5% | -39.9% | -65.1% | 18.9% | 16.0% | 16.4% | 5.0% | -649.0% | -196.8% | -219.8% | -194.5% | -29.2% | -124.3% | 49.0% | 44.8% | 27.4% | 48.8% | -14.3% | -4.6% | 5.5% | -104.1% | -152.0% | -289.8% | -447.7% | -326.6% | -349.2% | -340.1% | |
| -195.3% | -282.7% | -457.5% | -712.2% | -1,195.6% | -697.0% | -769.0% | -731.9% | -648.4% | -1,158.8% | -804.5% | -106.2% | -72.6% | -41.8% | -34.7% | -60.6% | 20.3% | 21.5% | 24.7% | 13.5% | -584.7% | -190.3% | -224.5% | -193.5% | -24.2% | -113.5% | 51.9% | 49.2% | 33.0% | 52.9% | -2.6% | 6.3% | 15.8% | -81.3% | -126.5% | -253.5% | -404.8% | -296.5% | -319.6% | -312.6% | |
| -239.5% | -334.1% | -504.9% | -742.3% | -1,094.1% | -644.7% | -11.4% | -73.7% | -86.3% | -265.0% | 478.9% | 85.0% | 58.1% | 39.2% | -96.7% | -103.0% | -55.8% | -63.6% | -62.8% | -75.6% | -576.4% | -147.4% | 2.9% | 13.4% | 12.8% | -36.7% | 38.6% | 46.9% | 54.3% | 29.9% | 6.9% | -15.5% | -17.5% | -23.5% | -170.3% | -272.0% | -379.5% | -334.5% | -356.1% | -352.4% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -22.0% | -29.6% | -40.5% | -56.2% | -86.3% | -52.7% | -75.2% | -98.3% | -118.2% | -190.1% | -94.9% | -49.7% | -49.5% | -43.8% | -51.0% | -78.7% | 24.1% | 23.8% | 28.9% | 16.2% | -106.2% | -74.9% | -93.3% | -99.6% | -21.4% | -78.6% | 45.6% | 48.2% | 29.7% | 56.0% | -0.9% | 2.7% | 7.8% | -21.7% | -31.1% | -44.2% | -57.7% | -61.1% | -67.2% | -69.8% | |
| -16.2% | -21.2% | -28.4% | -37.4% | -52.2% | -38.3% | -31.4% | -37.5% | -39.3% | -49.9% | -23.2% | -15.1% | -14.2% | -12.3% | -12.6% | -20.3% | 14.9% | 14.0% | 16.6% | 8.6% | -50.2% | -36.7% | -31.6% | -31.7% | -9.4% | -29.1% | 29.4% | 30.4% | 17.8% | 37.7% | -0.6% | 2.1% | 6.1% | -16.5% | -24.0% | -33.5% | -44.0% | -47.5% | -53.2% | -54.5% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -64 | -37 | -44 | -66 | -48 | -32 | -140 | -60 | -42 | – | -104 | -77 | -80 | -83 | -162 | -141 | -144 | -100 | -113 | -113 | -106 | -112 | -126 | -76 | -94 | -96 | -265 | -241 | -62 | -66 | -137 | -69 | -106 | -64 | -67 | -36 | -37 | -57 | -36 | -29 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -3.5 | -3.2 | -3.7 | -11.8 | – | – | – | – | – | – | -2.5 | -2.4 | -1.1 | -0.5 | -52.9 | -5.5 | -3.6 | – | – | – | – | – | – | – | |
| 73.8% | 71.7% | 70.1% | 66.5% | 60.5% | 72.7% | 41.8% | 38.2% | 33.3% | 26.2% | 24.5% | 30.5% | 28.7% | 28.1% | 24.7% | 25.8% | 61.6% | 59.0% | 57.3% | 53.0% | 47.3% | 49.0% | 33.9% | 31.8% | 43.7% | 37.0% | 64.5% | 63.1% | 59.8% | 67.3% | 72.6% | 76.9% | 77.5% | 76.3% | 77.2% | 75.7% | 76.2% | 77.7% | 79.2% | 78.1% | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -1.29 | -1.57 | -1.93 | -2.28 | -2.81 | -2.41 | -2.33 | -2.52 | -2.41 | -2.73 | -2.86 | -1.55 | -1.46 | -1.18 | -1.10 | -1.63 | 1.06 | 0.98 | 1.05 | 0.48 | -2.46 | -1.88 | -1.86 | -1.56 | -0.43 | -1.20 | 2.35 | 2.20 | 1.19 | 2.94 | -0.05 | 0.16 | 0.45 | -1.12 | -1.45 | -1.84 | -2.16 | -2.04 | -1.96 | -1.78 | |
| 0.66 | 0.56 | 0.42 | 0.32 | 0.24 | 0.35 | 0.30 | 0.34 | 0.37 | 0.24 | 0.36 | 1.46 | 2.01 | 2.83 | 3.17 | 2.70 | 5.24 | 4.58 | 4.25 | 3.52 | 0.42 | 0.99 | 0.83 | 0.81 | 1.78 | 1.06 | 4.52 | 4.48 | 3.61 | 5.55 | 2.08 | 2.49 | 2.83 | 1.38 | 1.15 | 0.73 | 0.53 | 0.69 | 0.61 | 0.57 | |
| 5.88 | 5.32 | 4.76 | 4.06 | 3.26 | 4.58 | 3.09 | 2.56 | 2.04 | 1.44 | 3.02 | 3.12 | 2.94 | 2.70 | 2.16 | 2.08 | 4.41 | 4.13 | 3.63 | 2.94 | 2.31 | 2.51 | 2.00 | 1.57 | 2.02 | 1.53 | 5.15 | 4.57 | 4.02 | 5.24 | 5.97 | 5.81 | 5.71 | 5.17 | 4.67 | 4.16 | 3.74 | 3.34 | 2.92 | 2.55 | |
| -1.59 | -1.86 | -2.12 | -2.38 | -2.57 | -2.23 | -0.03 | -0.25 | -0.32 | -0.62 | 1.70 | 1.24 | 1.17 | 1.11 | -3.07 | -2.78 | -2.92 | -2.91 | -2.67 | -2.66 | -2.42 | -1.46 | 0.02 | 0.11 | 0.23 | -0.39 | 1.75 | 2.10 | 1.96 | 1.66 | 0.14 | -0.39 | -0.50 | -0.32 | -1.95 | -1.97 | -2.02 | -2.30 | -2.18 | -2.01 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.